Skip to main content
Premium Trial:

Request an Annual Quote

AxCell to Conduct Pilot Study for Pluvita

NEW YORK, Dec. 11 - AxCell Biosciences said Tuesday it had agreed to run a pilot program for Pluvita to determine protein interactions based on signal transduction research.

Axcell said it would identify full-length peptides that bind to a compound Pluvita has earmarked for the research program. 

Financial and other terms of the agreement were not disclosed. 

The deal signals a furthering of the relationship between the two companies. Last month, Pluvita of Bethesda, Md., signed a three-year deal for access to AxCell ProChart database, which contains information on signal transduction pathways in the human proteome.

"AxCell's platform technology should help us to identify drugs that target pathways related to a specific disease while avoiding the pathways associated with unwanted side effects,” Gary Kurtzman, CEO of Pluvita, said in a statement.

Pluvita is developing drugs for cancer and reproductive diseases. 

AxCell Biosciences of Princeton, NJ, is a subsidiary of Cytogen.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.